Tocilizumab for chronic joint inflammation from CPPD
Treatments studied
Part of Bones, joints & muscles clinical trials.
This trial tests whether a drug called tocilizumab can reduce joint pain and swelling in people with chronic CPPD (calcium pyrophosphate deposition disease), a type of arthritis. It is for those who have not gotten enough relief from standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of CPPD (a type of arthritis caused by calcium crystals in the joints).
- You have had ongoing joint pain for more than 3 months, or you get at least 2 joint attacks per month.
- You have more than 3 painful joints and your overall pain score is above 40 on a 0-100 scale.
- You have tried or cannot use usual treatments like colchicine, NSAIDs, steroids, or anakinra without success or side effects.
- You are not taking certain other arthritis drugs or immunosuppressants (like methotrexate or biologics), and if you were, you have stopped them for a required period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at calcium pyrophosphate deposition (CPPD) disease, a condition where crystals build up in joints and cause pain and swelling. It aims to learn more about how the disease acts in both sudden attacks and long-term joint problems, which could help improve treatment.
This study tests whether the drug baricitinib can help people with pseudogout (a type of arthritis caused by calcium crystals) by reducing joint pain and swelling. It is for people with either hand/wrist joint problems or frequent large joint swelling, and involves a biopsy of the knee or wrist.
This trial tests the drug tocilizumab (Actemra) to see if it helps reduce swelling in the aorta in people with giant cell arteritis (GCA) who are newly diagnosed or have had a flare. It may offer a targeted treatment for aortitis without using high-dose steroids.
This trial tests if colchicine can reduce pain and swelling in people with CPPD (calcium pyrophosphate deposition disease), a type of arthritis. If you have had a swollen, red, or warm joint in the last 3 months and your pain is moderate or higher, this study may offer a possible treatment.
This study tests a drug called tocilizumab (which calms inflammation) to see if it helps people with calciphylaxis, a painful skin condition linked to kidney disease. The drug might reduce pain and improve healing of skin sores.
This trial studies how doctors assess and manage immune-related arthritis or joint pain that happens after PD-1/PD-L1 cancer immunotherapy (sometimes with CTLA-4). It may help people get faster, more targeted care while monitoring safety.
Hear when a new Calcium Pyrophosphate Deposition Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.